2 ASX 200 shares I'd want to receive as a present today

Merry Christmas! Are there any stocks under your tree?

| More on:
A happy man and woman on a computer at Christmas, indicating a positive trend for retail shares.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I hope everyone who celebrates today is having a wonderful, festive start to their day. Did you receive a pair of socks today? What about a pair of stocks? Receiving S&P/ASX 200 Index (ASX: XJO) shares as a gift is probably not the most popular present, but I'd love it.

Wouldn't it be great to receive a present that gives you cash year after year, and the gift (hopefully) becomes more and more valuable as time goes on?

If I could choose what ASX 200 shares I receive as a present, that'd mean I don't have to pay for them myself or worry about their valuation. It could be fun to receive some of the most exciting ASX 200 shares as a present, which have exceptionally high price-earnings (P/E) ratios.

I'd happily receive some shares of the below two businesses.

Pro Medicus Ltd (ASX: PME)

Pro Medicus may well be the best ASX 200 share out there. Not only does it have enormous profit margins, but its revenue and profit growth outlook is very impressive.

This company describes itself as a leading healthcare informatics business, providing a full range of medical imaging software and services to hospitals, imaging centres, and healthcare groups worldwide. It claims to offer one of the most comprehensive end-to-end offerings in healthcare imaging.

Pro Medicus' operating profit (EBIT) margin is over 60%, one of the highest on the ASX. Any new revenue can also significantly increase the net profit after tax (NPAT).

It's regularly winning new contracts – earlier this week, it announced a A$30 million, 7-year deal with Duly Health and Care, the largest independent, multi-specialty physician-directed medical group in the Midwest USA.

If it continues winning contracts, then the outlook will keep improving.

Why do I want it as a present rather than buying it myself? According to the forecast on Commsec, the ASX 200 share is valued at close to 235x FY25's estimated earnings.

That's an astonishingly high price-earnings (P/E) ratio. But, if there were one business on the ASX to say it's justified, I'd say it's this one.

TechnologyOne Ltd (ASX: TNE)

In my books, TechnologyOne is another of the most impressive companies on the ASX. It claims to be Australia's largest enterprise software company, with locations across six countries. Its main offering is a global software as a service (SaaS) enterprise resource planning (ERP) solution that transforms business. Its customer base includes more than 1,300 leading corporations, government agencies, local councils, and universities.

When I consider the appeal of an ASX growth share, I ask myself an important question: How big can the business' operations/profit become in five or ten years?

The more a business can grow, the more likely it is to deliver pleasing shareholder returns.

The company's long-term target is to reach at least $1 billion of annual recurring revenue (ARR) by FY30, thanks to a combination of a high loyalty rate and strong growth. When the company reported its FY24 result, it said its total ARR was $470.2 million.

It's aiming to achieve revenue growth of at least 15% from its existing customer base each year as customers take up more of the ASX 200 share's products and modules. The average ARR from customers has grown from $100,000 in FY12 to almost $400,000 in FY24.

The company is aiming to reach a profit before tax (PBT) margin of 35% in the coming years, up from 30% in FY24.

Overall, I think this business has a lot of growth potential, and I'd love to be gifted some of its shares and financially contribute to its success.

According to the forecasts on Commsec, the TechnologyOne share price is valued at 75x FY25's estimated earnings.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Technology One. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus and Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

A young female investor with brown curly hair and wearing a yellow top and glasses sits at her desk using her calculator to work out how much her ASX dividend shares will pay this year
Opinions

Why I'm still investing in ASX shares during tariff uncertainty

There are a few reasons why I plan to continue investing even during uncertainty.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Opinions

Why I'm buying more of these 2 ASX stocks ahead of earnings season

I've been excited about buying these investments.

Read more »

Business women working from home with stock market chart showing per cent change on her laptop screen.
Opinions

1 month until ASX earnings season begins: how I'm preparing

It’s almost reporting time. Here’s what I’m looking at.

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Opinions

Potential buys: 2 compelling ASX shares I like

These ASX shares have an exciting future.

Read more »

Smiling man at the wheel of a car.
Opinions

2 ASX auto stocks to buy — and 1 to sell: experts

Analysts have shared fresh insights into 3 ASX auto shares -- and not all of them are in the buy…

Read more »

A male investor sits at his desk pondering at his laptop screen with a piece of paper in his hand.
Opinions

ASX retail share whose 'fundamentals have deteriorated significantly': expert

Christopher Watt from Bell Potter explains his views on this former market darling.

Read more »

A young woman looks at something on her laptop, wondering what will come next.
Opinions

3 soaring ASX 200 large-cap shares that are now overvalued: experts

Two experts say this trio of ASX 200 large-caps have overshot and it's time to take some profits.

Read more »

Man sitting in a plane seat works on his laptop.
Opinions

Expert reveals 2 ASX stocks to sell — and 1 is a recent IPO

Toby Grimm from Baker Young shares his insights.

Read more »